Atlas Trials

B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma

Clinical trial NCT03246750 · COMPLETED

Trial details

NCT number
NCT03246750
Sponsor
The Thai Lymphoma Study Group
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Extranodal NK/T-cell Lymphoma
Start date
2019-01-30
Primary completion
2024-04-10
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.